News
Brian Eno posted an open letter to Microsoft, calling on the company to cut its ties with Israel’s genocidal campaign against Palestinians. He also pledged to donate the fee that Microsoft paid him ...
We report 5-year efficacy and safety outcomes from the phase III KEYNOTE-407 study (ClinicalTrials.gov identifier: NCT02775435).Eligible patients with previously untreated, metastatic squamous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results